REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $319,000 | +13.9% | 8,200 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $280,000 | -25.7% | 8,200 | -1.4% | 0.00% | -40.0% |
| Q4 2020 | $377,000 | +64.6% | 8,320 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $229,000 | -84.6% | 8,320 | -79.4% | 0.00% | -85.7% |
| Q2 2020 | $1,485,000 | +13.7% | 40,320 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $1,306,000 | -17.0% | 40,320 | 0.0% | 0.02% | +31.2% |
| Q4 2019 | $1,573,000 | +7.9% | 40,320 | -1.5% | 0.02% | 0.0% |
| Q3 2019 | $1,458,000 | -30.7% | 40,945 | 0.0% | 0.02% | -30.4% |
| Q2 2019 | $2,104,000 | -12.5% | 40,945 | -2.4% | 0.02% | -11.5% |
| Q1 2019 | $2,404,000 | +36.6% | 41,945 | 0.0% | 0.03% | +13.0% |
| Q4 2018 | $1,760,000 | -44.4% | 41,945 | 0.0% | 0.02% | -23.3% |
| Q3 2018 | $3,167,000 | – | 41,945 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |